In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...